Meyers C A, Valentine A D, Wong F C, Leeds N E
Department of Neuro-Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
J Neuropsychiatry Clin Neurosci. 1994 Summer;6(3):285-8. doi: 10.1176/jnp.6.3.285.
A 41-year-old man developed subacute neurotoxicity associated with interleukin-2 and tumor necrosis factor therapy for metastatic renal cell carcinoma. Cognitive deficits revealed on neuropsychological testing and frontal lobe perfusion deficits revealed on SPECT resolved after 1 month. Findings suggest possible neuroanatomic and physiologic substrates of cytokine neurotoxicity.